Role of brahmi syrup in management of attention deficit hyperactivity disorder

A physiological assessment of brahmi as a medhyarasayana in the management of vatik unmada w.s.r. to attention deficit hyperactivity disorder(ADHD)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029510

Enrollment

Registered

2020-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: F01-F99- Mental, Behavioral and Neurodevelopmental disorders

Interventions

Intervention1: Brahmi syrup: Brahmi syrup-20 ml BD orally for 45 days Intervention2: Brahmi syrup: Brahmi syrup -20 ml BD orally for 45 days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: school going childern aged between 7-12 years of age with poor academic achievements,poor concentration, increased distractibility, motor restlessness will be included in the study

Exclusion criteria

Exclusion criteria: childern not fulfilling the DSM-4 criteria for diagnosis of ADHD Childeren with mild to severe mental retardation will be included childeren with chronic ailments like tuberculosis, malignancy etc. will be excluded childeren with oppositional defiant disorder, conduct disorders will be excluded

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective criteriaTimepoint: 15 days	—

Secondary

Measure	Time frame
Improvement in subjective criteria with no associated complaintsTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Meenakshi meena

Dr sarvepalli Radhakrishnan rajasthan Ayurved university jodhpur

dr_dcsharma@yahoo.com9461691454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026